NCT03617055

Brief Summary

The aim of the study is to investigate the role of serum cystatin C (sCysC) as an early predictor for both diagnosis and short term outcome evaluation of acute kidney injury (AKI) in neonates with perinatal asphyxia admitted to Neonatal Intensive Care Unit (NICU) of Assiut University Children Hospital

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

August 7, 2018

Status Verified

July 1, 2018

Enrollment Period

1 year

First QC Date

August 1, 2018

Last Update Submit

August 5, 2018

Conditions

Keywords

kidney injury, asphyxia,cystatin c

Outcome Measures

Primary Outcomes (1)

  • serum cystatin C (sCysC) as an early predictor of acute kidney injury (AKI) in neonates with perinatal asphyxia.

    measuring serum cystatin c in neonates with perinatal asphyxia

    one year

Secondary Outcomes (1)

  • is to determine the incidence of Acute kidney injury in neonates with perinatal asphyxia.

    one year

Interventions

serum cystatin cDIAGNOSTIC_TEST

Blood sample for serum cystatin c will be taken on the first and third days of life for all neonates with clinical or laboratory signs of perinatal asphyxia who are admitted to NICU for early detection of AKI in the study group.

Eligibility Criteria

Age1 Hour - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

all full term neonates with documented perinatal asphyxiaby by one of the following indicators: (i) Presence of a sentinel hypoxic event immediately before or during delivery; (ii) History of fetal distress (bradycardia, late decelerations, absence of heart rate variability); (iii) Need for neonatal resuscitation at delivery; (iv) 1-min Apgar score \<3 or 5-min Apgar score \<7; or metabolic acidosis (BE \> 10 in cord blood).

You may qualify if:

  • all full term neonates who are admitted to neonatal intensive care unit of Assiut University Children Hospital through the period from Jan. 2019 to Jan. 2020 with documented perinatal asphyxia

You may not qualify if:

  • preterm neonates \< 37 weeks, neonates who died within the first 24 hours of admission, neonates with any congenital anomalies like skeletal, renal or urinary tract, neonates with AKI for any cause other than asphyxia and neonates with maternal history of renal failure .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (11)

  • Abdulkader RC, Liborio AB, Malheiros DM. Histological features of acute tubular necrosis in native kidneys and long-term renal function. Ren Fail. 2008;30(7):667-73. doi: 10.1080/08860220802212460.

    PMID: 18704814BACKGROUND
  • Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012 Mar;81(5):442-8. doi: 10.1038/ki.2011.379. Epub 2011 Nov 23.

    PMID: 22113526BACKGROUND
  • Mathur NB, Agarwal HS, Maria A. Acute renal failure in neonatal sepsis. Indian J Pediatr. 2006 Jun;73(6):499-502. doi: 10.1007/BF02759894.

    PMID: 16816511BACKGROUND
  • Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol. 2006 Jul;21(7):931-8. doi: 10.1007/s00467-006-0118-2. Epub 2006 May 25.

    PMID: 16773403BACKGROUND
  • Subramanian S, Agarwal R, Deorari AK, Paul VK, Bagga A. Acute renal failure in neonates. Indian J Pediatr. 2008 Apr;75(4):385-91. doi: 10.1007/s12098-008-0043-4. Epub 2008 May 18.

    PMID: 18536895BACKGROUND
  • Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res. 1998 Jun;43(6):738-45. doi: 10.1203/00006450-199806000-00005.

    PMID: 9621982BACKGROUND
  • Oncel MY, Canpolat FE, Arayici S, Alyamac Dizdar E, Uras N, Oguz SS. Urinary markers of acute kidney injury in newborns with perinatal asphyxia (.). Ren Fail. 2016 Jul;38(6):882-8. doi: 10.3109/0886022X.2016.1165070. Epub 2016 Apr 7.

    PMID: 27055689BACKGROUND
  • Durkan AM, Alexander RT. Acute kidney injury post neonatal asphyxia. J Pediatr. 2011 Feb;158(2 Suppl):e29-33. doi: 10.1016/j.jpeds.2010.11.010.

    PMID: 21238703BACKGROUND
  • Bagshaw SM, Bellomo R. Early diagnosis of acute kidney injury. Curr Opin Crit Care. 2007 Dec;13(6):638-44. doi: 10.1097/MCC.0b013e3282f07570.

    PMID: 17975383BACKGROUND
  • Kandasamy Y, Smith R, Wright IM. Measuring cystatin C to determine renal function in neonates. Pediatr Crit Care Med. 2013 Mar;14(3):318-22. doi: 10.1097/PCC.0b013e318271f4a5.

    PMID: 23392363BACKGROUND
  • Jetton JG, Askenazi DJ. Acute kidney injury in the neonate. Clin Perinatol. 2014 Sep;41(3):487-502. doi: 10.1016/j.clp.2014.05.001. Epub 2014 Jul 22.

    PMID: 25155722BACKGROUND

MeSH Terms

Conditions

Acute Kidney InjuryAsphyxia

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Central Study Contacts

nafesa refaat, MD

CONTACT

Mohammed amir, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mohammed Abdel tawab sabra

Study Record Dates

First Submitted

August 1, 2018

First Posted

August 6, 2018

Study Start

January 1, 2019

Primary Completion

January 1, 2020

Study Completion

July 1, 2020

Last Updated

August 7, 2018

Record last verified: 2018-07